SOURCE: Kalorama Information

Kalorama Information

September 22, 2010 10:50 ET

"Safe Bet" Diabetes Market Spurs Competition and New Products

NEW YORK, NY--(Marketwire - September 22, 2010) -  The diabetes market is one of the fastest growing areas within the pharmaceutical sector, one of the few areas that is likely to continue to grow at double digit rates, according to healthcare market research publisher Kalorama Information. The promise of a near-certain market for patients has lead to competition among top names in pharmaceuticals to try to secure a position in the market with a new product, according to "The World Market for Diabetes Treatments."

Diabetes is typically treated using diet control, exercise, and the monitoring of blood glucose several times a day. In some cases oral medication and/or insulin is prescribed, especially where diet or exercise is not enough, creating opportunity for drug makers. According to the report, the total diabetes therapeutic market reached $24.9 billion in 2009, increasing 16.4% from the previous year. This level of growth is expected to continue at least for the next two years, according to Kalorama Information. Major contributing factors to growth are increasing obesity and an aging worldwide population.

"Diabetes is seen as kind of a 'safe bet' development area as pharmacos try to carve out a piece of this income stream with a treatment that is a bit more effective," said Bruce Carlson, Publisher of Kalorama Information. "Unfortunately there has been little or no improvement in the numbers through diet and exercise. Even if there were improvement, there would still be a large pool of existing patients requiring treatment."

Top companies in the market include NovoNordisk, Sanofi-Aventis, GlaxoSmithKline, Merck and Tekada. Kalorama's report lists over 100 new diabetes products in the development pipeline by these firms and others. While the entire market is considered safer for investment than other pharmaceutical markets, individual product success is never guaranteed; products will succeed or fail, depending on their effectiveness, marketing, and how well they fit with medical practice. 

The report, "The World Market for Diabetes Treatments," contains more information on epidemiology, products, companies operating in the market, forecasts and market estimates. The report is available at:

About Kalorama Information
Kalorama Information supplies the latest in independent market research in the life sciences, as well as a full range of custom research services. We routinely assist the media with healthcare topics. Follow us on Twitter ( and LinkedIn (

Contact Information